According to the report, the high throughput screening market was valued at USD 23.20 billion in 2024 and is expected to reach USD 33.90 billion by 2034, registering a CAGR of 3.20% during the forecast period. The report highlights key factors such as advancements in automation technologies, increasing demand for efficient drug discovery, and growing investments in pharmaceutical research.

Get a sample of the report @ https://www.emergenresearch.co....m/request-sample/268